Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 11Desmoid Tumors 6Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Paraproteinemias 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Leukemia 1Hematologic Diseases 1HIV Infections 1Granulosa cell tumor of the ovary 1Corneal Diseases 1Breast Neoplasms 1Breast Cancer Metastatic 1Blood Protein Disorders 1Advanced Solid Tumors 1AIDS-related Kaposi sarcoma 1

Interventions

Cyclophosphamide 9Pemetrexed 6pembrolizumab 5fludarabine 5Gemcitabine 5Cisplatin 5Carboplatin 5ponatinib 4atezolizumab 4Rituximab 4Dexamethasone 4Bevacizumab 4130-nm albumin-bound paclitaxel 4Sunitinib 3Melphalan 3Doxorubicin 3Bortezomib 3tetulomab tetraxetan lu-177 2pralsetinib 2pomalidomide 2osimertinib 2napabucasin 2isatuximab 2fludarabine phosphate 2ficlatuzumab 2entrectinib 2entinostat 2durvalumab 2cobimetinib 2capmatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms by Histologic Type × nirogacestat × Clear all
NCT00878189 2019-11-12

A Trial In Patients With Advanced Cancer And Leukemia

Pfizer

Phase 1 Completed
72 enrolled 49 charts
Other hematologic neoplasm

Leukemia, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡